Parker, RobertRabideau, Dustin J.Sax, PaulTierney, CamlinDaar, Eric S.Collier, Ann C.Losina, ElenaFreedberg, Kenneth2017-06-152017Parker, Robert A., Dustin J. Rabideau, Paul E. Sax, Camlin Tierney, Eric S. Daar, Ann C. Collier, Elena Losina, and Kenneth A. Freedberg. 2017. “Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 64 (11): 1612-1614. doi:10.1093/cid/cix176. http://dx.doi.org/10.1093/cid/cix176.http://nrs.harvard.edu/urn-3:HUL.InstRepos:33030029Abstract In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.en-USHIVmissing medicationself-reportadherencevirologic failure.Journal Article2017-06-1510.1093/cid/cix176